Cancer’s hiding place, exposed.

Delivering clarity, confidence, and peace of mind. iCAD’s ProFound Suite of cancer detection solutions are clinically proven to improve breast cancer detection and radiologist performance.

A screening revolution has arrived. The difference is ProFound.  Built with the latest in deep-learning, convolutional neural networks, iCAD’s ProFound AI cancer detection products offer high-performing, concurrent-read, cancer-detection and workflow solutions that rapidly and accurately analyzes each 2D or 3D mammogram image, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy.

ProFound Detection V4 FDA Cleared This next-generation AI solution, trained using advanced deep learning convolutional neural networks (CNN), offers advancements in cancer detection and specificity, achieving a 6.3% improved area under the receiver operating characteristic curve (AUC) over prior version, significantly improving the identification of hard-to-find and aggressive cancers while reducing false positives. This fourth-generation version introduces an option for clinicians to incorporate a prior exam into a current exam’s analysis.

Early detection is critical! When breast cancer is detected early and still localized, the 5-year relative survival rate is 99%,5 according to the American Cancer Society.

Features

• Deep Learning Detection: Identifies malignant soft tissue densities and calcifications with high precision.
• Concurrent Read Workflow: Integrates seamlessly into radiologist workflows for real-time analysis.
• Prior Exam Comparison: Option to include previous exams for enhanced diagnostic context.
• Lesion & Case Scoring: Provides actionable scores to prioritize cases and support decision-making.
• FDA-Cleared & CE Marked: Approved for use in multiple regions, ensuring global clinical reliability.